Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
7.41
0.00 (0.00%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Absci Market Cap
Absci has a market cap or net worth of $1.16 billion as of June 18, 2026. Its market cap has increased by 217.78% in one year.
Market Cap
1.16B
Enterprise Value
1.03B
1-Year Change
217.78%
Ranking
Category
Stock Price
$7.41
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $1.16B, an increase of 172.99%. That is a compound annual growth rate of 22.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.16B | 120.13% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | 423.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 1.33B |
| Avalyn Pharma | 1.31B |
| MapLight Therapeutics | 1.31B |
| Damora Therapeutics | 1.31B |
| Hemab Therapeutics Holdings | 1.29B |
| Zenas BioPharma | 1.25B |
| MannKind | 1.22B |
| Wave Life Sciences | 1.19B |